Market Closed -
Other stock markets
|
Pre-market 07:10:41 am | |||
757.7 USD | -0.30% | 757.1 | -0.07% |
10:45am | Wegovy weight loss sustained for four years in trial, Novo Nordisk says | RE |
10:03am | Foreign investment in Germany reaches new record | RE |
Financials (USD)
Sales 2024 * | 42.81B | Sales 2025 * | 52.47B | Capitalization | 682B |
---|---|---|---|---|---|
Net income 2024 * | 11.93B | Net income 2025 * | 16.55B | EV / Sales 2024 * | 16.4 x |
Net Debt 2024 * | 19.98B | Net Debt 2025 * | 15.29B | EV / Sales 2025 * | 13.3 x |
P/E ratio 2024 * |
56.7
x | P/E ratio 2025 * |
40.8
x | Employees | 43,000 |
Yield 2024 * |
0.69% | Yield 2025 * |
0.79% | Free-Float | 99.8% |
Latest transcript on Eli Lilly and Company
1 day | -0.36% | ||
1 week | -1.17% | ||
Current month | -3.00% | ||
1 month | +0.81% | ||
3 months | +1.98% | ||
6 months | +23.66% | ||
Current year | +29.98% |
Managers | Title | Age | Since |
---|---|---|---|
David Ricks
CEO | Chief Executive Officer | 56 | 95-12-31 |
Anat Ashkenazi
DFI | Director of Finance/CFO | 51 | 00-12-31 |
Ruth Gimeno
PSD | President | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 63 | 21-01-24 | |
Ralph Alvarez
BRD | Director/Board Member | 68 | 09-03-31 |
Jon Fyrwald
BRD | Director/Board Member | 63 | 04-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
6.49% | 17 M€ | +6.46% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-13 | 757.7 | -0.30% | 1,848,926 |
24-05-10 | 760 | -1.50% | 2,082,289 |
24-05-09 | 771.6 | -0.45% | 2,522,085 |
24-05-08 | 775 | -0.36% | 2,089,934 |
24-05-07 | 777.8 | +1.45% | 2,879,447 |
Delayed Quote Nyse, May 13, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+29.98% | 682B | |
+32.24% | 586B | |
-3.52% | 364B | |
+18.59% | 327B | |
+4.07% | 285B | |
+16.42% | 240B | |
+9.46% | 209B | |
-8.88% | 203B | |
+7.09% | 165B | |
-1.22% | 161B |
- Stock Market
- Equities
- LLY Stock